Abstract

CLINICAL EFFECTS OF TRIPHALA GUGGULU ON DIABETIC MACULAR EDEMA

Arvind Gautam*, Aarti Chaurasiya and Manoj Kumar

Abstract

Diabetic macular edema (DME) is the largest cause of visual acuity loss in Diabetes. It mainly affects the central vision from early stages of retinopathy, and it is the most common sight-threatening complication of diabetic retinopathy, especially in older type 2 diabetic patients. For the present study25 patients (50 eyes) were registered and were randomized into two groups comprising of 26 eyes in group I and 24 eyes in Group II. Triphala Guggulu is given in Group I i.e. Trial Group and starch capsules for control Group II. The clinical assessment is primarily done on the basis of central macular thickness and visual acuity. The results of the study showed that the visual acuity and central retinal thickness was improved in more patients in trial group as compared to placebo group.

Keywords: Triphala Guggulu.